Negative contractile reserve with low-dose dobutamine in patients with ischemic cardiomyopathy investigated by gated myocardial perfusion SPECT. 2010

Jaume Candell-Riera, and Guillermo Romero-Farina, and Marta Milá, and Santiago Aguadé-Bruix, and Gemma Cuberas, and David García-Dorado, and
Servicio de Cardiologia, Area del Corazon, Hospital Universitario Vall d'Hebron, Universidad Autonoma de Barcelona, Pg. Vall d'Hebron, 119-129, 08035 Barcelona, Spain. jcandell@vhebron.net

OBJECTIVE To investigate negative contractile responses in the left ventricle during low-dose dobutamine (LDD) gated single-photon emission computed tomography (SPECT) in patients with ischemic cardiomyopathy. METHODS Sixty-eight consecutive patients (mean age, 60 + or - 11 years; 7 male) with ischemic cardiomyopathy (i.e., left ventricular ejection fraction [LVEF] < or = 40%) were evaluated using gated-SPECT at rest and during LDD infusion. Associations between a negative contractile reserve (i.e., a > or = 1-grade improvement in wall thickening score with LDD infusion) and scintigraphic viability criteria and coronary angiography findings were analyzed. RESULTS Some 42.6% (29/68) of patients had a negative contractile reserve in one or more segments. In 14.7% (n=10), the LVEF decreased by > or = 4% with LDD. These patients had more segments with a negative contractile reserve (2.8 + or - 2.5 vs. 0.87 + or - 0.40; P=.042), and the cut-off value on receiver operating characteristic curve analysis was > or =2 segments with a negative contractile reserve (sensitivity 70%, specificity 74%, positive likelihood ratio 2.71, negative likelihood ratio 0.40). Some 94% (74/79) of segments with a negative contractile reserve were in viable myocardium (i.e. normal or viable on scintigraphy). Twelve of 17 segments with akinesia or severe hypokinesia and a negative contractile reserve satisfied scintigraphic viability criteria, with the majority (10/12) lying in territories supplied by a patent coronary artery. CONCLUSIONS A negative contractile reserve was not uncommon in patients with ischemic cardiomyopathy and was associated with a general decrease in left ventricular systolic function. It was observed mainly in myocardial segments that appeared viable on scintigraphy and were supplied by a patent coronary artery.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009200 Myocardial Contraction Contractile activity of the MYOCARDIUM. Heart Contractility,Inotropism, Cardiac,Cardiac Inotropism,Cardiac Inotropisms,Contractilities, Heart,Contractility, Heart,Contraction, Myocardial,Contractions, Myocardial,Heart Contractilities,Inotropisms, Cardiac,Myocardial Contractions
D009943 Organophosphorus Compounds Organic compounds that contain phosphorus as an integral part of the molecule. Included under this heading is broad array of synthetic compounds that are used as PESTICIDES and DRUGS. Organophosphorus Compound,Organopyrophosphorus Compound,Organopyrophosphorus Compounds,Compound, Organophosphorus,Compound, Organopyrophosphorus,Compounds, Organophosphorus,Compounds, Organopyrophosphorus
D002316 Cardiotonic Agents Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). Cardiac Stimulant,Cardiac Stimulants,Cardioprotective Agent,Cardioprotective Agents,Cardiotonic,Cardiotonic Agent,Cardiotonic Drug,Inotropic Agents, Positive Cardiac,Myocardial Stimulant,Myocardial Stimulants,Cardiotonic Drugs,Cardiotonics,Agent, Cardioprotective,Agent, Cardiotonic,Drug, Cardiotonic,Stimulant, Cardiac,Stimulant, Myocardial
D004280 Dobutamine A catecholamine derivative with specificity for BETA-1 ADRENERGIC RECEPTORS. It is commonly used as a cardiotonic agent after CARDIAC SURGERY and during DOBUTAMINE STRESS ECHOCARDIOGRAPHY. Dobucor,Dobuject,Dobutamin Fresenius,Dobutamin Hexal,Dobutamin Solvay,Dobutamin-ratiopharm,Dobutamina Inibsa,Dobutamina Rovi,Dobutamine (+)-Isomer,Dobutamine Hydrobromide,Dobutamine Hydrochloride,Dobutamine Lactobionate,Dobutamine Phosphate (1:1) Salt, (-)-Isomer,Dobutamine Tartrate,Dobutamine Tartrate (1:1), (R-(R*,R*))-Isomer,Dobutamine Tartrate (1:1), (S-(R*,R*))-Isomer,Dobutamine, (-)-Isomer,Dobutamine, Phosphate (1:1) Salt (+)-Isomer,Dobutrex,Lilly 81929,Oxiken,Posiject,Dobutamin ratiopharm,Hydrobromide, Dobutamine,Hydrochloride, Dobutamine,Lactobionate, Dobutamine,Tartrate, Dobutamine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D015609 Organotechnetium Compounds Organic compounds that contain technetium as an integral part of the molecule. These compounds are often used as radionuclide imaging agents. Compounds, Organotechnetium

Related Publications

Jaume Candell-Riera, and Guillermo Romero-Farina, and Marta Milá, and Santiago Aguadé-Bruix, and Gemma Cuberas, and David García-Dorado, and
June 2022, European journal of nuclear medicine and molecular imaging,
Jaume Candell-Riera, and Guillermo Romero-Farina, and Marta Milá, and Santiago Aguadé-Bruix, and Gemma Cuberas, and David García-Dorado, and
January 2002, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology,
Jaume Candell-Riera, and Guillermo Romero-Farina, and Marta Milá, and Santiago Aguadé-Bruix, and Gemma Cuberas, and David García-Dorado, and
January 2003, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology,
Jaume Candell-Riera, and Guillermo Romero-Farina, and Marta Milá, and Santiago Aguadé-Bruix, and Gemma Cuberas, and David García-Dorado, and
January 2000, Echocardiography (Mount Kisco, N.Y.),
Jaume Candell-Riera, and Guillermo Romero-Farina, and Marta Milá, and Santiago Aguadé-Bruix, and Gemma Cuberas, and David García-Dorado, and
May 2024, Journal of imaging informatics in medicine,
Jaume Candell-Riera, and Guillermo Romero-Farina, and Marta Milá, and Santiago Aguadé-Bruix, and Gemma Cuberas, and David García-Dorado, and
February 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Jaume Candell-Riera, and Guillermo Romero-Farina, and Marta Milá, and Santiago Aguadé-Bruix, and Gemma Cuberas, and David García-Dorado, and
January 2000, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology,
Jaume Candell-Riera, and Guillermo Romero-Farina, and Marta Milá, and Santiago Aguadé-Bruix, and Gemma Cuberas, and David García-Dorado, and
July 2005, Annals of nuclear medicine,
Jaume Candell-Riera, and Guillermo Romero-Farina, and Marta Milá, and Santiago Aguadé-Bruix, and Gemma Cuberas, and David García-Dorado, and
October 2003, The American journal of cardiology,
Jaume Candell-Riera, and Guillermo Romero-Farina, and Marta Milá, and Santiago Aguadé-Bruix, and Gemma Cuberas, and David García-Dorado, and
June 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Copied contents to your clipboard!